Nosocomial Environmental Contamination by MERS-CoV Investigated
By LabMedica International staff writers Posted on 04 Jan 2016 |
Image: Applied Biosystems ABI 373 XLDNA sequencer (Photo courtesy of Perkin-Elmer).
Although Middle East Respiratory Syndrome coronavirus (MERS-CoV) is characterized by a risk of nosocomial transmission, the detailed mode of transmission and period of virus shedding from infected patients are poorly understood.
The potential role of environmental contamination by MERS-CoV in health care settings and defining the period of viable virus shedding from MERS patients has been investigated using reverse transcription polymerase chain reaction (PCR), and isolating viable virus by cultures.
Scientists at the Chungbuk National University (Cheongju City, Republic of Korea) and their colleagues enrolled four laboratory-confirmed MERS patients, hospitalized in two hospitals from June 8, 2015, to July 3, 2015. Respiratory specimens and environmental samples were collected and cultured from all patients during the later stages of clinical disease. Viral ribonucleic acid (RNA) was extracted from all samples and MERS-CoV and the RNA amplified and quantified. Amplicons were purified and sequenced on an ABI 373 XLDNA sequencer (Perkin-Elmer; Foster City, CA, USA).
Many environmental surfaces of MERS patient rooms, including points frequently touched by patients or healthcare workers, were contaminated by MERS-CoV. Viral RNA was detected up to five days from environmental surfaces following the last positive PCR from patients' respiratory specimens. MERS-CoV RNA was detected in samples from anterooms, medical devices, and air-ventilating equipment. In addition, MERS-CoV was isolated from environmental objects such as bed sheets, bedrails, intravenous fluid hangers, and X-ray devices. During the late clinical phase of MERS, viable virus could be isolated in three of the four enrolled patients on day 18 to day 25 after symptom onset.
The authors concluded that most of touchable surfaces in MERS units were contaminated by patients and health care workers and the viable virus could shed through respiratory secretion from clinically fully recovered patients. These results emphasize the need for strict environmental surface hygiene practices, and sufficient isolation period based on laboratory results rather than solely on clinical symptoms. The study was published on December 17, 2015, in the journal Clinical Infectious Diseases.
Related Links:
Chungbuk National University
Perkin-Elmer
The potential role of environmental contamination by MERS-CoV in health care settings and defining the period of viable virus shedding from MERS patients has been investigated using reverse transcription polymerase chain reaction (PCR), and isolating viable virus by cultures.
Scientists at the Chungbuk National University (Cheongju City, Republic of Korea) and their colleagues enrolled four laboratory-confirmed MERS patients, hospitalized in two hospitals from June 8, 2015, to July 3, 2015. Respiratory specimens and environmental samples were collected and cultured from all patients during the later stages of clinical disease. Viral ribonucleic acid (RNA) was extracted from all samples and MERS-CoV and the RNA amplified and quantified. Amplicons were purified and sequenced on an ABI 373 XLDNA sequencer (Perkin-Elmer; Foster City, CA, USA).
Many environmental surfaces of MERS patient rooms, including points frequently touched by patients or healthcare workers, were contaminated by MERS-CoV. Viral RNA was detected up to five days from environmental surfaces following the last positive PCR from patients' respiratory specimens. MERS-CoV RNA was detected in samples from anterooms, medical devices, and air-ventilating equipment. In addition, MERS-CoV was isolated from environmental objects such as bed sheets, bedrails, intravenous fluid hangers, and X-ray devices. During the late clinical phase of MERS, viable virus could be isolated in three of the four enrolled patients on day 18 to day 25 after symptom onset.
The authors concluded that most of touchable surfaces in MERS units were contaminated by patients and health care workers and the viable virus could shed through respiratory secretion from clinically fully recovered patients. These results emphasize the need for strict environmental surface hygiene practices, and sufficient isolation period based on laboratory results rather than solely on clinical symptoms. The study was published on December 17, 2015, in the journal Clinical Infectious Diseases.
Related Links:
Chungbuk National University
Perkin-Elmer
Latest Molecular Diagnostics News
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset